IGHE and allergic disease: A regulatory, IL-10-producing DC phenotype is of special interest for the treatment of allergic diseases where the treatment aim is to downregulate allergen-specific Th2 responses and the associated clinical symptoms (allergen-specific Th2-responses, IgE-mediated mast cell and basophil activation, allergic inflammation).